Financiën Eli Lilly and Company

Aandelen

LLY

US5324571083

Farmaceutische producten

Geschatte realtime Cboe BZX Andere beurzen 20:44:41 14-01-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.069,29 ^USD	-0,73%		-3,59%	-0,59%

20:13	Novo Nordisk blijft zoeken naar overnames om obesitasportfolio uit te breiden, aldus CEO	MT
20:01	AbbVie wil zijn aanwezigheid op de obesitasmarkt uitbreiden	RE

Voorlopige winst- en verliesrekening: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Omzet ¹	24.540	28.318	28.541	34.124	45.043	63.694	76.900	90.010
Variatie	-	15,4%	0,79%	19,56%	32%	41,41%	20,73%	17,05%
EBITDA ¹	8.589	10.005	9.472	8.584	16.079	28.703	37.841	45.423
Variatie	-	16,48%	-5,32%	-9,38%	87,32%	78,51%	31,84%	20,04%
Bedrijfsresultaat (EBIT) ¹	7.265	8.457	7.950	7.057	14.313	26.599	35.203	42.718
Variatie	-	16,41%	-6%	-11,24%	102,83%	85,84%	32,35%	21,35%
Betaalde rente ¹	-326,6	-314,4	-268,8	-312,3	-605,4	-734,3	-723,4	-628,5
Resultaat voor belastingen (EBT) ¹	7.230	6.156	6.806	6.555	12.680	25.048	32.375	39.225
Variatie	-	-14,86%	10,57%	-3,7%	93,46%	97,54%	29,25%	21,16%
Nettowinst (verlies) ¹	6.194	5.582	6.245	5.240	10.590	20.397	28.334	35.203
Variatie	-	-9,88%	11,88%	-16,08%	102,08%	92,6%	38,91%	24,24%
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Omzet ¹	7.440	6.806	6.740	6.773	8.000	7.810	6.488	6.942	7.302	6.960	8.312	9.499	9.353	8.768	11.303	11.439	13.533	12.728	15.558	17.601	17.860	17.059	18.688	20.002	21.150
Variatie	-	-8,53%	-0,96%	0,49%	18,12%	-2,37%	-16,93%	6,99%	5,19%	-4,68%	19,43%	14,27%	-1,53%	-6,26%	28,91%	1,21%	18,3%	-5,94%	22,23%	13,13%	1,47%	-4,48%	9,55%	7,03%	5,74%
EBITDA ¹	2.824	2.223	2.353	2.446	2.982	3.046	1.679	2.373	2.375	1.982	2.618	986,4	2.855	3.049	4.703	2.214	6.113	4.316	7.467	8.320	8.812	9.138	10.195	11.848	11.957
Variatie	-	-21,26%	5,85%	3,96%	21,88%	2,15%	-44,88%	41,34%	0,09%	-16,54%	32,1%	-62,33%	189,46%	6,78%	54,27%	-52,92%	176,09%	-29,4%	73,02%	11,41%	5,92%	3,69%	11,57%	16,21%	0,92%
Bedrijfsresultaat (EBIT) ¹	2.456	1.873	1.984	2.064	2.536	2.610	1.330	2.010	2.000	1.620	2.252	575,4	2.468	2.648	4.289	1.747	5.628	3.853	6.989	7.850	7.862	7.969	8.869	10.088	10.587
Variatie	-	-23,74%	5,93%	4,04%	22,86%	2,92%	-49,04%	51,13%	-0,5%	-19,01%	39,04%	-74,45%	328,83%	7,32%	61,96%	-59,26%	222,1%	-31,54%	81,38%	12,32%	0,16%	1,36%	11,3%	13,74%	4,94%
Charge d'intérêts ¹	-83,4	-82,3	-86,9	-76,6	-74	-77,9	-71	-61,4	-58,5	-68,6	-74,3	-75,7	-93,7	-133,8	-146,3	-144,9	-180,4	-195,4	-209	-114,6	-232,2	-201,5	-199,5	-196	-194,5
Resultaat voor belastingen (EBT) ¹	-	1.476	1.594	1.245	-	-	-	-	-	-	2.089	427,2	2.509	2.536	3.517	1.588	5.039	3.456	6.776	7.232	7.684	-	-	-	-
Variatie	-	-	7,96%	-21,87%	-	-	-	-	-	-	-	-79,55%	487,27%	1,09%	38,69%	-54,84%	217,22%	-31,41%	96,07%	6,73%	6,25%	-	-	-	-
Nettowinst (verlies) ¹	2.117	1.355	1.390	1.110	1.726	1.903	952,5	1.452	1.938	1.345	1.763	-57,4	2.190	2.243	2.967	970,3	4.410	2.759	5.660	5.582	6.336	5.866	6.810	7.556	8.397
Variatie	-	-35,97%	2,58%	-20,15%	55,49%	10,24%	-49,94%	52,41%	33,48%	-30,59%	31,1%	-103,26%	3.914,63%	2,43%	32,28%	-67,3%	354,48%	-37,43%	105,14%	-1,38%	13,5%	-7,43%	16,11%	10,94%	11,14%
Datum van publicatie	29/01/21	27/04/21	3/08/21	26/10/21	3/02/22	28/04/22	4/08/22	1/11/22	2/02/23	27/04/23	8/08/23	2/11/23	6/02/24	30/04/24	8/08/24	30/10/24	6/02/25	1/05/25	7/08/25	30/10/25	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Nettoschuld ¹	12.914	12.976	14.027	22.298	30.221	27.802	13.043	-9.561
Variatie	-	0,48%	8,1%	58,96%	35,53%	-8%	-53,09%	-173,3%
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	1.388	1.310	1.854	3.448	5.058	5.809	6.307	6.152
Variatie	-	-5,63%	41,57%	85,92%	46,7%	14,84%	8,57%	-2,44%
Vrije kasstroom (FCF) ¹	5.112	5.951	5.230	792,5	3.760	11.210	17.425	25.423
Variatie	-	16,42%	-12,11%	-84,85%	374,46%	198,13%	55,44%	45,9%
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Winstgevendheid
EBITDA-marge (%)	35%	35,33%	33,19%	25,15%	35,7%	45,06%	49,21%	50,46%
EBIT-marge (%)	29,6%	29,86%	27,85%	20,68%	31,78%	41,76%	45,78%	47,46%
EBT-marge (%)	29,46%	21,74%	23,85%	19,21%	28,15%	39,33%	42,1%	43,58%
Nettomarge (%)	25,24%	19,71%	21,88%	15,36%	23,51%	32,02%	36,84%	39,11%
FCF-marge (%)	20,83%	21,01%	18,32%	2,32%	8,35%	17,6%	22,66%	28,24%
Vrije kasstroom/nettoresultaat (%)	82,53%	106,61%	83,75%	15,12%	35,51%	54,96%	61,5%	72,22%
Winstgevendheid
ROA	14,42%	15,58%	14,62%	9,23%	14,84%	23,04%	25,76%	26,77%
ROE	175,45%	101,73%	73,22%	48,93%	84,84%	104,9%	80,04%	62,06%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,5x	1,3x	1,48x	2,6x	1,88x	0,97x	0,34x	-
Schuld/vrije kasstroom	2,53x	2,18x	2,68x	28,14x	8,04x	2,48x	0,75x	-
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	5,66%	4,63%	6,5%	10,1%	11,23%	9,12%	8,2%	6,84%
CAPEX / EBITDA (%)	16,16%	13,09%	19,58%	40,16%	31,46%	20,24%	16,67%	13,54%
CAPEX / FCF (%)	27,15%	22,01%	35,45%	435,03%	134,51%	51,82%	36,19%	24,2%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	7,119	7,964	7,831	4,694	9,754	21,81	36,38	40,43
Variatie	-	11,87%	-1,67%	-40,06%	107,79%	123,59%	66,8%	11,13%
Dividend per aandeel ¹	2,96	3,4	3,92	4,52	5,2	5,893	6,632	7,392
Variatie	-	14,86%	15,29%	15,31%	15,04%	13,34%	12,54%	11,46%
Nettoactief per aandeel ¹	5,9	9,411	11,2	11,93	15,76	29,98	51,47	79,86
Variatie	-	59,51%	19,04%	6,45%	32,16%	90,24%	71,69%	55,15%
WPA ¹	6,79	6,12	6,9	5,8	11,71	22,89	32,18	39,02
Variatie	-	-9,87%	12,75%	-15,94%	101,9%	95,46%	40,58%	21,26%
Aantal aandelen (in duizend)	906.582	906.592	950.178	899.307	900.432	895.381	895.381	895.381
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-